NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.

Stringent control of the NF-kappaB and type I interferon signaling pathways is critical to effective host immune responses, yet the molecular mechanisms that negatively regulate these pathways are poorly understood. Here, we show that NLRC5, a member of the highly conserved NOD-like protein family, can inhibit the IKK complex and ...
RIG-I/MDA5 function. NLRC5 inhibited NF-kappaB-dependent responses by interacting with IKKalpha and IKKbeta and blocking their phosphorylation. It also interacted with RIG-I and MDA5, but not with MAVS, to inhibit RLR-mediated type I interferon responses. Consistent with these observations, NLRC5-specific siRNA knockdown not only enhanced the activation of NF-kappaB and its responsive genes, TNF-alpha and IL-6, but also promoted type I interferon signaling and antiviral immunity. Our findings identify NLRC5 as a negative regulator that blocks two central components of the NF-kappaB and type I interferon signaling pathways and suggest an important role for NLRC5 in homeostatic control of innate immunity.
Mesh Terms:
Animals, Cloning, Molecular, DEAD-box RNA Helicases, Humans, I-kappa B Kinase, Immunity, Innate, Inflammation, Interferon Type I, Intracellular Signaling Peptides and Proteins, Ligands, Mice, NF-kappa B, Phosphorylation, Signal Transduction, Toll-Like Receptors
Cell
Date: Apr. 30, 2010
Download Curated Data For This Publication
151448
Switch View:
  • Interactions 8